Livongo to Add Telehealth Functionality; Roche Appoints new NA Diagnostics CEO

Today, two major news items were observed including Livongo’s new partnerships with MDLIVE and Doctor On Demand telehealth platforms as well as Roche’s appointment of Matthew Sause as CEO for its North American diagnostics group. Below, FENIX provides thoughts and insights into the Livongo and Roche announcements.

About The Author

Matthew Maryniak

President of Fenix Group International

Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.

If you receive our email blasts, you already have an account.

Purchase Blast$599.00

You can read the article’s full content online after purchase.